Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2025. Start Trial.
Date Value
September 30, 2026 156.69M
June 30, 2026 161.74M
March 31, 2026 139.95M
Date Value
December 31, 2025 120.78M
September 30, 2025 102.25M
June 30, 2025 85.35M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Korsana Biosciences, Inc. 43.39M
IRulya Therapeutics, Inc. 30.76M
PepGen Inc. 52.70M
Q32 Bio, Inc. 15.94M
Oncolytics Biotech, Inc. 13.18M